Iobenguane Sulfate I 123

CHEMBL3989523 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
640.3 g/mol
LogP
Phase
4

A sulfate i 123 form of iobenguane with the same therapeutic properties. This compound is a guanethidine analogue that, when labeled with radioactive iodine, is used for imaging or treating tumors of the adrenal medulla (pheochromocytoma) and related neuroendocrine tumors.

Peso molecular

640,3000 g/mol

TPSA

212,00 Ų

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

N=C(N)NCc1cccc([123I])c1.N=C(N)NCc1cccc([123I])c1.O=S(=O)(O)O

InChI

InChI=1S/2C8H10IN3.H2O4S/c2*9-7-3-1-2-6(4-7)5-12-8(10)11;1-5(2,3)4/h2*1-4H,5H2,(H4,10,11,12);(H2,1,2,3,4)/i2*9-4;

Molecular Formula

C16H22I2N6O4S

HBD / HBA

6 / 6

Enlaces Rotables

4

Átomos Pesados

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A sulfate i 123 form of iobenguane with the same therapeutic properties. This compound is a guanethidine analogue that, when labeled with radioactive iodine, is used for imaging or treating tumors of the adrenal medulla (pheochromocytoma) and related neuroendocrine tumors.

Yes, Iobenguane Sulfate I 123 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989523. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 56840904. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.